Free tool
Stocks above their 200-day average
We cover 183 companies trading above their own 200-day average. The median market value in the group is $76.75M. Across the group, the median move over the past trading day is 0.00%. 100% of the 183 with a 200-day average trade above it. Price change over the past year runs from −36.3% to +257.5% across the middle 80 percent of the group, with a median of +31.0%.
Other lists in this group
Table
183 of 10,735 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| ABT | Abbott Laboratories | $198.74B | Large cap | −11.83% |
| GILD | Gilead Sciences, Inc. | $184.47B | Large cap | +32.51% |
| PFE | Pfizer Inc. | $161.30B | Large cap | +18.72% |
| DHR | Danaher Corporation | $151.40B | Large cap | +5.61% |
| VRTX | Vertex Pharmaceuticals Incorporated | $138.63B | Large cap | +40.66% |
| BMY | Bristol-Myers Squibb Company | $138.03B | Large cap | +47.01% |
| MDT | Medtronic plc | $117.78B | Large cap | +2.29% |
| MCK | McKesson Corporation | $104.54B | Large cap | +31.57% |
| ELV | Elevance Health, Inc. | $87.30B | Large cap | +32.12% |
| REGN | Regeneron Pharmaceuticals, Inc. | $83.89B | Large cap | +39.36% |
| CI | The Cigna Group | $74.22B | Large cap | −4.84% |
| ARGX | argenx SE | $65.51B | Large cap | +47.90% |
| COR | Cencora, Inc. | $62.55B | Large cap | +13.45% |
| MRNA | Moderna, Inc. | $59.75B | Large cap | +496.25% |
| TAK | Takeda Pharmaceutical Company Limited | $58.60B | Large cap | +22.68% |
| CAH | Cardinal Health, Inc. | $55.45B | Large cap | +61.05% |
| EW | Edwards Lifesciences Corporation | $52.32B | Large cap | +12.21% |
| BDX | Becton, Dickinson and Company | $51.81B | Large cap | +25.97% |
| NTRA | Natera, Inc. | $48.53B | Large cap | +107.59% |
| HUM | Humana Inc. | $46.96B | Large cap | +33.14% |
| RVMD | Revolution Medicines, Inc. | $46.18B | Large cap | +466.35% |
| HLN | Haleon plc | $44.72B | Large cap | +6.13% |
| TEVA | Teva Pharmaceutical Industries Limited | $44.19B | Large cap | +110.08% |
| A | Agilent Technologies, Inc. | $43.80B | Large cap | +31.46% |
| IQV | IQVIA Holdings Inc. | $43.04B | Large cap | +38.51% |
| ONC | BeOne Medicines AG | $42.58B | Large cap | +25.21% |
| WAT | Waters Corporation | $40.67B | Large cap | +40.57% |
| VEEV | Veeva Systems Inc. | $39.78B | Large cap | −16.58% |
| RPRX | Royalty Pharma plc | $35.71B | Large cap | +74.00% |
| RMD | ResMed Inc. | $34.13B | Large cap | −15.77% |
| ILMN | Illumina, Inc. | $33.95B | Large cap | +125.88% |
| DXCM | DexCom, Inc. | $33.65B | Large cap | +16.47% |
| GEHC | GE HealthCare Technologies Inc. | $33.35B | Large cap | −1.15% |
| BIIB | Biogen Inc. | $32.66B | Large cap | +62.12% |
| CNC | Centene Corporation | $32.34B | Large cap | +127.01% |
| BNTX | BioNTech SE | $28.28B | Large cap | +9.27% |
| MTD | Mettler-Toledo International Inc. | $28.10B | Large cap | +8.81% |
| LH | Labcorp Holdings Inc. | $27.39B | Large cap | +21.14% |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.12% |
| ROIV | Roivant Sciences Ltd. | $26.55B | Large cap | +206.51% |
| INCY | Incyte Corporation | $25.97B | Large cap | +51.01% |
| WST | West Pharmaceutical Services, Inc. | $24.63B | Large cap | +42.61% |
| STE | STERIS plc | $23.09B | Large cap | −4.41% |
| GH | Guardant Health, Inc. | $22.94B | Large cap | +169.17% |
| THC | Tenet Healthcare Corporation | $21.89B | Large cap | +50.70% |
| GMAB | Genmab A/S | $21.42B | Large cap | +36.20% |
| VTRS | Viatris Inc. | $19.35B | Large cap | +66.19% |
| ZBH | Zimmer Biomet Holdings, Inc. | $19.34B | Large cap | −4.32% |
| MEDP | Medpace Holdings, Inc. | $17.28B | Large cap | +30.74% |
| JAZZ | Jazz Pharmaceuticals plc | $16.89B | Large cap | +100.35% |
| ASND | Ascendis Pharma A/S | $16.41B | Large cap | +29.66% |
| NBIX | Neurocrine Biosciences, Inc. | $15.92B | Large cap | +13.36% |
| SOLV | Solventum Corporation | $15.58B | Large cap | +25.57% |
| BBIO | BridgeBio Pharma, Inc. | $15.52B | Large cap | +60.05% |
| CRL | Charles River Laboratories International, Inc. | $14.09B | Large cap | +81.27% |
| EXEL | Exelixis, Inc. | $14.05B | Large cap | +45.68% |
| RVTY | Revvity, Inc. | $13.93B | Large cap | +42.93% |
| BAX | Baxter International Inc. | $13.70B | Large cap | +8.90% |
| ICLR | ICON Public Limited Company | $13.03B | Large cap | −2.91% |
| CORT | Corcept Therapeutics Incorporated | $12.95B | Large cap | +71.81% |
| PEN | Penumbra, Inc. | $12.72B | Large cap | +21.02% |
| BMRN | BioMarin Pharmaceutical Inc. | $12.70B | Large cap | +11.85% |
| ELAN | Elanco Animal Health Incorporated | $12.53B | Large cap | +35.64% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $12.52B | Large cap | +308.99% |
| FMS | Fresenius Medical Care AG | $12.51B | Large cap | −3.21% |
| MDGL | Madrigal Pharmaceuticals, Inc. | $12.45B | Large cap | +26.78% |
| HALO | Halozyme Therapeutics, Inc. | $12.41B | Large cap | +46.30% |
| TEM | Tempus AI, Inc. | $12.40B | Large cap | −6.49% |
| EHC | Encompass Health Corporation | $11.92B | Large cap | −1.75% |
| DVA | DaVita Inc. | $11.41B | Large cap | +30.89% |
| TECH | Bio-Techne Corporation | $11.35B | Large cap | +29.33% |
| BTSG | BrightSpring Health Services, Inc. | $11.32B | Large cap | +156.37% |
| CYTK | Cytokinetics, Incorporated | $11.01B | Large cap | +109.36% |
| AXSM | Axsome Therapeutics, Inc. | $10.85B | Large cap | +69.99% |
| GKOS | Glaukos Corporation | $10.65B | Large cap | +89.83% |
| KRYS | Krystal Biotech, Inc. | $10.65B | Large cap | +143.67% |
| MOH | Molina Healthcare, Inc. | $10.57B | Large cap | +13.35% |
| PRAX | Praxis Precision Medicines, Inc. | $10.54B | Large cap | +704.28% |
| KYMR | Kymera Therapeutics, Inc. | $10.53B | Large cap | +197.09% |
| BIO | Bio-Rad Laboratories, Inc. | $10.40B | Large cap | +32.71% |
| HSIC | Henry Schein, Inc. | $10.30B | Large cap | +31.02% |
| RGEN | Repligen Corporation | $10.25B | Large cap | +51.67% |
| APGE | Apogee Therapeutics, Inc. | $10.21B | Large cap | +257.11% |
| ATRA | Atara Biotherapeutics, Inc. | $94.15M | Micro cap | −24.05% |
| ACRV | Acrivon Therapeutics, Inc. | $93.42M | Micro cap | +52.94% |
| ECOR | electroCore, Inc. | $93.31M | Micro cap | +86.49% |
| ICCC | ImmuCell Corporation | $91.00M | Micro cap | +64.26% |
| RLYB | Rallybio Corporation | $89.64M | Micro cap | +257.63% |
| ATHE | Alterity Therapeutics Limited | $86.64M | Micro cap | −4.40% |
| CING | Cingulate Inc. | $85.36M | Micro cap | +29.19% |
| ACET | Adicet Bio, Inc. | $83.79M | Micro cap | −26.01% |
| APLM | Apollomics, Inc. | $76.75M | Micro cap | +320.55% |
| OSTX | OS Therapies Incorporated | $76.68M | Micro cap | −34.00% |
| LONA | LeonaBio, Inc. | $75.47M | Micro cap | +95.25% |
| NRXS | NeurAxis, Inc. | $74.84M | Micro cap | +146.28% |
| MNOV | MediciNova, Inc. | $72.85M | Micro cap | +10.45% |
| FBIOP | Fortress Biotech, Inc. | $71.45M | Micro cap | +131.74% |
| PMVP | PMV Pharmaceuticals, Inc. | $70.03M | Micro cap | −7.75% |
| INCR | InterCure Ltd. | $69.65M | Micro cap | +265.03% |
| INMB | INmune Bio Inc. | $67.86M | Micro cap | +19.56% |
| RNXT | RenovoRx, Inc. | $67.24M | Micro cap | +61.08% |
| SER | Serina Therapeutics, Inc. | $66.80M | Micro cap | −47.29% |
| BOLD | Boundless Bio, Inc. | $66.31M | Micro cap | +155.70% |
| TLPH | Talphera, Inc. | $65.40M | Micro cap | +133.33% |
| MYO | Myomo, Inc. | $60.60M | Micro cap | +36.61% |
| INKT | MiNK Therapeutics, Inc. | $60.16M | Micro cap | −26.22% |
| XLO | Xilio Therapeutics, Inc. | $59.55M | Micro cap | −5.63% |
| COCH | Envoy Medical, Inc. | $56.82M | Micro cap | −37.09% |
| SCYX | SCYNEXIS, Inc. | $56.41M | Micro cap | +579.04% |
| NTRB | Nutriband Inc. | $54.70M | Micro cap | −29.80% |
| PRPO | Precipio, Inc. | $54.43M | Micro cap | +99.25% |
| HOWL | Werewolf Therapeutics, Inc. | $48.05M | Micro cap | −25.65% |
| MLSS | Milestone Scientific Inc. | $47.87M | Micro cap | −10.10% |
| ALGS | Aligos Therapeutics, Inc. | $46.65M | Micro cap | −33.72% |
| ELUT | Elutia Inc. | $44.29M | Micro cap | −54.75% |
| NEPH | Nephros, Inc. | $43.98M | Micro cap | 0.00% |
| HBIO | Harvard Bioscience, Inc. | $34.83M | Micro cap | +44.34% |
| CCEL | Cryo-Cell International, Inc. | $34.67M | Micro cap | −3.19% |
| NSYS | Nortech Systems Incorporated | $33.62M | Micro cap | +30.74% |
| KYNB | Kyntra Bio, Inc. | $32.82M | Micro cap | −22.66% |
| RMTI | Rockwell Medical, Inc. | $31.90M | Micro cap | +438.44% |
| QNCX | Quince Therapeutics, Inc. | $31.84M | Micro cap | +100.71% |
| IGC | IGC Pharma, Inc. | $31.49M | Micro cap | −31.62% |
| BRNS | Barinthus Biotherapeutics plc | $28.86M | Micro cap | −38.04% |
| GRDX | GridAI Technologies Corp. | $28.75M | Micro cap | +111.52% |
| TXMD | TherapeuticsMD, Inc. | $26.39M | Micro cap | +103.57% |
| MRKR | Marker Therapeutics, Inc. | $24.18M | Micro cap | +54.26% |
| FEMY | Femasys Inc. | $23.87M | Micro cap | +711.11% |
| BFRI | Biofrontera Inc. | $22.72M | Micro cap | +77.91% |
| RVP | Retractable Technologies, Inc. | $21.85M | Micro cap | −12.05% |
| COCP | Cocrystal Pharma, Inc. | $21.57M | Micro cap | −27.74% |
| CCM | Concord Medical Services Holdings Limited | $21.49M | Micro cap | −10.47% |
| ALLR | Allarity Therapeutics, Inc. | $21.32M | Micro cap | −15.72% |
| LFWD | Lifeward Ltd. | $20.93M | Micro cap | +0.03% |
| PMI | Picard Medical, Inc. | $20.13M | Micro cap | +113.51% |
| NCEL | NewcelX Ltd. | $19.52M | Micro cap | −84.77% |
| VYNE | VYNE Therapeutics Inc | $19.07M | Micro cap | +8660.74% |
| LEXX | Lexaria Bioscience Corp. | $18.24M | Micro cap | +1146.05% |
| BCDA | BioCardia, Inc. | $18.02M | Micro cap | −38.66% |
| CYCN | Cyclerion Therapeutics, Inc. | $17.97M | Micro cap | +61.48% |
| BIVI | BioVie Inc. | $17.83M | Micro cap | +30.25% |
| ADIL | Adial Pharmaceuticals, Inc. | $17.43M | Micro cap | −37.47% |
| CMMB | Chemomab Therapeutics Ltd. | $16.85M | Micro cap | −25.57% |
| ADVB | Advanced Biomed Inc. | $15.27M | Micro cap | +13.24% |
| PHIO | Phio Pharmaceuticals Corp. | $13.94M | Micro cap | −40.89% |
| HSCS | HeartSciences Inc. | $13.47M | Micro cap | −11.54% |
| APRE | Aprea Therapeutics, Inc. | $12.34M | Micro cap | −38.75% |
| ASBP | Aspire Biopharma Holdings, Inc. | $11.68M | Micro cap | −60.93% |
| KPRX | Kiora Pharmaceuticals, Inc. | $11.46M | Micro cap | −9.44% |
| TOVX | Theriva Biologics, Inc. | $11.16M | Micro cap | −42.10% |
| LUCY | Lucyd, Inc | $9.73M | Micro cap | −42.05% |
| MBAI | Check-Cap Ltd. | $9.33M | Micro cap | +943.08% |
| BMGL | Basel Medical Group Ltd | $9.29M | Micro cap | +202.81% |
| IMRN | Immuron Limited | $9.20M | Micro cap | −35.77% |
| XBIO | Xenetic Biosciences, Inc. | $9.04M | Micro cap | +35.92% |
| SKYE | Skye Bioscience, Inc. | $8.92M | Micro cap | −41.62% |
| XWEL | XWELL, Inc. | $8.55M | Micro cap | −6.93% |
| CNSP | CNS Pharmaceuticals, Inc. | $8.48M | Micro cap | −13.51% |
| NDRA | ENDRA Life Sciences Inc. | $8.16M | Micro cap | +32.36% |
| ALZN | Alzamend Neuro, Inc. | $8.06M | Micro cap | −32.11% |
| NVNO | enVVeno Medical Corporation | $7.97M | Micro cap | −63.76% |
| ICCM | IceCure Medical Ltd | $7.85M | Micro cap | +132.49% |
| TRIB | Trinity Biotech plc | $7.80M | Micro cap | +547.97% |
| INM | InMed Pharmaceuticals Inc. | $7.64M | Micro cap | −36.44% |
| CURX | Curanex Pharmaceuticals Inc | $7.21M | Micro cap | −1.29% |
| JUNS | Jupiter Neurosciences, Inc. | $6.66M | Micro cap | +236.24% |
| AMIX | Autonomix Medical, Inc. | $6.20M | Micro cap | +440.68% |
| LIMN | Liminatus Pharma, Inc. | $6.19M | Micro cap | +46.03% |
| HCWB | HCW Biologics Inc. | $4.96M | Micro cap | −55.15% |
| XAIR | Beyond Air, Inc. | $4.89M | Micro cap | +117.98% |
| GLMD | Galmed Pharmaceuticals Ltd. | $4.48M | Micro cap | +211.51% |
| SILO | Silo Pharma, Inc. | $4.38M | Micro cap | +290.62% |
| UPC | Universe Pharmaceuticals INC | $3.53M | Micro cap | +44.57% |
| CLDI | Calidi Biotherapeutics, Inc. | $3.49M | Micro cap | −19.16% |
| TNON | Tenon Medical, Inc. | $3.48M | Micro cap | +297.71% |
| GNPX | Genprex, Inc. | $3.25M | Micro cap | −54.10% |
| BIAF | bioAffinity Technologies, Inc. | $3.02M | Micro cap | −31.59% |
| PFSA | Profusa, Inc. | $2.58M | Micro cap | −86.13% |
| VRAX | Virax Biolabs Group Limited | $2.21M | Micro cap | +365.55% |
| SHPH | Shuttle Pharmaceuticals Holdings, Inc. | $2.10M | Micro cap | +7.65% |
| MNDR | Mobile-health Network Solutions | $1.92M | Micro cap | −69.91% |
| SCNI | Scinai Immunotherapeutics Ltd. | $1.48M | Micro cap | +93.92% |
| APM | Aptorum Group Ltd | $570.06K | Micro cap | +273.78% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.